Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. April 2016 06:55 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Provides Regulatory Update on Firdapse

CORAL GABLES, Fla., April 26, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
15. März 2016 16:30 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results

CORAL GABLES, Fla., March 15, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing...
10. März 2016 11:55 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Present at the 28th Annual ROTH Conference

CORAL GABLES, Fla., March 10, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
09. März 2016 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast on Wednesday, March 16th, 2016

CORAL GABLES, Fla., March 09, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
29. Februar 2016 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Observes Rare Disease Day 2016

CORAL GABLES, Fla., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
26. Februar 2016 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance

CORAL GABLES, Fla., Feb. 26, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
18. Februar 2016 11:38 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day

CORAL GABLES, Fla., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
17. Februar 2016 06:50 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Receives "Refusal to File" Letter From the FDA on Its NDA for Firdapse

CORAL GABLES, Fla., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
08. Februar 2016 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Initiation of Investigator-Sponsored Study of Firdapse in Patients With MuSK-Antibody Positive Myasthenia Gravis

CORAL GABLES, Fla., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
04. Februar 2016 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference

CORAL GABLES, Fla., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...

Vorherige Seite

Nächste Seite